RESEARCHER PROFILE

Johann Sellner

← Back to Karl Landsteiner University of Health Sciences

J

Karl Landsteiner University of Health Sciences

Multiple Sclerosis Research StudiesAcute Ischemic Stroke ManagementInfectious Encephalopathies and EncephalitisPeripheral Neuropathies and DisordersPolyomavirus and related diseases

Johann Sellner works in Multiple Sclerosis Research Studies, Acute Ischemic Stroke Management, Infectious Encephalopathies and Encephalitis, Peripheral Neuropathies and Disorders, Polyomavirus and related diseases. Recorded institutional associations include Paracelsus Medical University, TUM Klinikum, Christian Doppler Klinik.

274Publications
6,581Citations
42H-index

Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.

Selected research works

Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.

  1. EFNS guidelines on diagnosis and management of neuromyelitis optica

    2010 · 461 citations
  2. The role of TH17 cells in multiple sclerosis: Therapeutic implications

    2020 · 302 citations
  3. CXCL13 is the major determinant for B cell recruitment to the CSF during neuroinflammation

    2012 · 224 citations
  4. European consensus‐based (S2k) Guideline on the Management of Herpes Zoster – guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV), Part 2: Treatment

    2016 · 222 citations
  5. The increasing incidence and prevalence of female multiple sclerosis—A critical analysis of potential environmental factors

    2011 · 208 citations
  6. Cerebral venous thrombosis and severe acute respiratory syndrome coronavirus‐2 infection: A systematic review and meta‐analysis

    2021 · 164 citations
  7. Immunological Aspects of Approved MS Therapeutics

    2019 · 155 citations
  8. The clinical spectrum and immunobiology of parainfectious neuromyelitis optica (Devic) syndromes

    2009 · 142 citations
  9. Vitamin D Supplementation in Multiple Sclerosis: A Critical Analysis of Potentials and Threats

    2020 · 130 citations
  10. The international European Academy of Neurology survey on neurological symptoms in patients with COVID‐19 infection

    2020 · 111 citations
  11. A systematic review of neurological manifestations of SARS‐CoV‐2 infection: the devil is hidden in the details

    2020 · 110 citations
  12. Safety, tolerability, and activity of mesenchymal stem cells versus placebo in multiple sclerosis (MESEMS): a phase 2, randomised, double-blind crossover trial

    2021 · 110 citations
  13. European consensus‐based (S2k) Guideline on the Management of Herpes Zoster – guided by the European Dermatology Forum ( EDF ) in cooperation with the European Academy of Dermatology and Venereology ( EADV ), Part 1: Diagnosis

    2016 · 104 citations
  14. Experimental Herpes Simplex Virus Encephalitis: A Combination Therapy of Acyclovir and Glucocorticoids Reduces Long-Term Magnetic Resonance Imaging Abnormalities

    2003 · 103 citations
  15. MEsenchymal StEm cells for Multiple Sclerosis (MESEMS): a randomized, double blind, cross-over phase I/II clinical trial with autologous mesenchymal stem cells for the therapy of multiple sclerosis

    2019 · 96 citations
  16. Neutrophil to lymphocyte ratio predicts intracranial hemorrhage after endovascular thrombectomy in acute ischemic stroke

    2018 · 92 citations
  17. In bacterial meningitis cortical brain damage is associated with changes in parenchymal MMP-9/TIMP-1 ratio and increased collagen type IV degradation

    2005 · 91 citations
  18. Pathogenesis and pathophysiology of bacterial CNS infections

    2010 · 90 citations
  19. A global view of comorbidity in multiple sclerosis: a systematic review with a focus on regional differences, methodology, and clinical implications

    2020 · 88 citations
  20. Cerebrovascular manifestations of herpes simplex virus infection of the central nervous system: a systematic review

    2019 · 87 citations
  21. Fatal Necrotizing Encephalopathy after Treatment with Nivolumab for Squamous Non-Small Cell Lung Cancer: Case Report and Review of the Literature

    2018 · 79 citations
  22. Tumefactive MS lesions under fingolimod

    2013 · 78 citations
  23. EFNS ‐ENS guidelines for the use of PCR technology for the diagnosis of infections of the nervous system

    2012 · 74 citations
  24. Seizures and epilepsy in herpes simplex virus encephalitis: current concepts and future directions of pathogenesis and management

    2012 · 73 citations
  25. Herpes-simplex virus encephalitis is characterized by an early MMP-9 increase and collagen type IV degradation

    2006 · 68 citations

← Return to the university profile